Enanta Pharmaceuticals, Inc. Common Stock (NASDAQ: ENTA) last traded at $11.18, down 2.95% on the session. The quote above updates while this page is open; the figures below are drawn from Enanta Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Enanta Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker ENTA. Its market capitalisation is $325.62 million.
Valuation measures for Enanta Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $325.62M |
|---|---|
| Enterprise value | $488.00M |
| Price / sales | 4.99 |
| Price / book | 3.22 |
| Beta | 0.81 |
Trailing-twelve-month figures tagged in Enanta Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $65.26M |
|---|---|
| Net income (TTM) | -$63.23M |
| EPS (TTM) | -$2.42 |
| Operating margin | -89.99% |
| Return on equity | -62.56% |
| Cash | $33.42M |
Range and volume for ENTA over the past 52 weeks.
| 52-week high | $17.15 |
|---|---|
| 52-week low | $10.20 |
| Volume | 227.6K |
| Average volume | 228.8K |
| Previous close | $11.52 |
Invest a chosen dollar amount in Enanta Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ENTA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.